Yüklüyor......
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice
BRAF, a cellular oncogene and effector of RAS-mediated signaling, is activated by mutation in ~60% of melano-mas. Most of these mutations consist of a V600E substitution resulting in constitutive kinase activation. Mutant BRAF thus represents an important therapeutic target in melanoma. In an effort...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3125533/ https://ncbi.nlm.nih.gov/pubmed/19398955 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2009.95 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|